Last reviewed · How we verify
Ketamine 0.1 mg
At a glance
| Generic name | Ketamine 0.1 mg |
|---|---|
| Sponsor | Assiut University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Management of Pain in Lumbar Arthrodesis (PHASE4)
- Effect of Esketamine on Postoperative Sleep in Postmenopausal Women (NA)
- Postoperative Pain Monitoring With ANI in Lumbar Spine Surgery (NA)
- An Exploratory Study of the Efficacy and Safety of Esketamine and Dexmedetomidine in Non-Intubated ICU Patients With Hyperactive Delirium (PHASE4)
- Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstructive Sleep Apnea (NA)
- Magnesium Sulfate Versus Other Anesthesia Drugs to Reduce Agitation After Adenotonsillectomy in Pediatric Patients (NA)
- Ultrasound Guided Pecs Block and Ketamine Infusion for Preventing Chronic Pain in Patients Undergoing Breast Cancer Surgery (NA)
- Multi-center RCT of IV Ketamine Efficacy and Safety in Chronic Daily Headaches (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ketamine 0.1 mg CI brief — competitive landscape report
- Ketamine 0.1 mg updates RSS · CI watch RSS
- Assiut University portfolio CI